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Background: Adults with primary brain tumors and their caregivers have significant infor-
mation needs. This review assessed the effect of interventions to improve information
provision for adult primary brain tumor patients and/or their caregivers.
Methods: We included randomized or non-randomized trials testing educational interven-
tions that had outcomes of information provision, knowledge, understanding, recall, or
satisfaction with the intervention, for adults diagnosed with primary brain tumors and/or
their family or caregivers. PubMed, MEDLINE, EMBASE, and Cochrane Reviews databases
were searched for studies published between 1980 and June 2014.
Results:Two randomized controlled, 1 non-randomized controlled, and 10 single group pre–
post trials enrolled more than 411 participants. Five group, four practice/process change,
and four individual interventions assessed satisfaction (12 studies), knowledge (4 studies),
and information provision (2 studies). Nine studies reported high rates of satisfaction.Three
studies showed statistically significant improvements over time in knowledge and two
showed greater information was provided to intervention than control group participants,
although statistical testing was not performed.
Discussion:The trials assessed intermediate outcomes such as satisfaction, and only 4/13
reported on knowledge improvements. Few trials had a randomized controlled design and
risk of bias was either evident or could not be assessed in most domains.
Keywords: neuro-oncology, brain tumor, information, doctor–patient communication, caregivers
INTRODUCTION
The provision of appropriate and timely information, tailored to
the medical condition, needs, and preferences, is essential to allow
patients and their families to cope with the diagnosis, access sup-
portive resources, and reduce uncertainty and distress (1, 2). Infor-
mation provision is essential for participation in decision-making
and to enable patients to give informed consent for treatment
(3–5). It also may improve compliance with treatment (6). Both
during and after active treatment, information can aid patients
and their families to monitor symptoms and undertake self-care.
Information can also assist family members to develop skills to
undertake caring tasks (7–9).
A range of strategies have been developed to facilitate infor-
mation provision in the cancer setting more widely. Traditional
approaches include written information, videos, CD or, more
recently, websites and apps (10, 11). Strategies may also aim to
improve communication between patients and healthcare pro-
fessionals by means of treatment summary letters, provision of
audio-tapes of consultations to patients, and communication skills
training for doctors. Overall, these have been developed and eval-
uated widely for patients with cancer. Promising findings have
specifically been shown with the use of such strategies for those
with high needs, including patients requiring treatment for lung
cancer or palliative care, with promising findings (12, 13).
Specifically for patients with brain tumors, studies suggest that
they are not satisfied with the information that they have been
provided. Patients want to receive more information, and wish
the information to be more detailed (14–22). Further informa-
tion is particularly required in two areas: (1) fatigue, insomnia,
and psychological disturbance (17, 23); and (2) changes in physi-
cal function and body image (24). Caregivers require information
on how to provide care (25), and how to manage physical, cog-
nitive, and personality changes in the patient and cope with
changes in family roles (26). The reasons why these needs are
not well met are not clear; however, certain factors are appar-
ent. In terms of patient characteristics, distress resulting from the
diagnosis may impair some patients’ abilities to process infor-
mation, particularly as the brain is commonly understood to
define the “self” (27). Cognitive and physical changes resulting
from a brain tumor or its treatment may also impair informa-
tion seeking or comprehension for some patients (28). Cognitive
impairment is the most common deficiency in primary brain
tumor patients, particularly affecting executive function, visuo-
constructive abilities, attention, and verbal memory (29). Memory
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loss, information processing, and attention are commonly affected
by radiotherapy and chemotherapy (30). Deficits may also arise
due to the tumor itself, raised intracranial pressure, or as the
result of surgery (31). Cognitive impairment has been shown to
affect patients’ awareness of their prognosis and ability to process
information (32). Considering factors relating to healthcare pro-
fessionals, the information provided may be insufficient due to
clinicians’ views of what patients need. For example, some health-
care professionals may hold back “unnecessary” information in
an attempt to “protect” patients from distress, particularly with
regard to issues such as preparing wills, advanced health direc-
tives, or the immediacy of palliative care required (33). Mate-
rials used to convey information also have limitations, as they
often require higher levels of literacy than is common in the
population (34).
Patient, healthcare professional, and interactive issues are also
likely to impact how well interventions aiming to improve infor-
mation provision will reach patients with brain tumors and
improve their satisfaction with care. Although some (but by no
means all) informational interventions have been well studied
in general cancer populations, the cognitive impairments expe-
rienced by brain tumor patients and the resulting concerns of
this group are unique, and it cannot be assumed that inter-
ventions will be equally effective when applied to these patients
and their caregivers. This review thus aimed to examine whether
patient-, caregiver-, or healthcare professional-directed interven-
tions improve information provision, satisfaction with the inter-
vention, or other commonly assessed outcomes (35) such as
knowledge, understanding, or recall for adults diagnosed with
primary brain tumors and/or their family or caregivers.
MATERIALS AND METHODS
CRITERIA FOR CONSIDERING STUDIES FOR THIS REVIEW
Randomized and non-randomized trials including single arm
studies were eligible for inclusion. To be included, studies needed
to test one or more interventions, which tested an educational
component (i.e., involving knowledge transfer, using any format
or materials) and which reported one or more of the outcomes:
information provision, knowledge, understanding, recall, or satis-
faction with the intervention. There were no language restrictions.
Case reports, personal narratives, editorials, commentaries, and
reviews were excluded.
As this review was concerned with outcomes for adults diag-
nosed with primary brain tumors and/or their informal caregivers,
studies with both adults and children need to report outcomes for
adults (18+ years) and children (<18 years) separately, or at least
75% of the sample needed to be aged 18+ years. Similarly, at least
75% of patients needed to be diagnosed with primary (malignant
or benign) brain tumors, or outcomes needed to be reported for
primary brain tumor patients separately. Studies involving care-
givers were eligible either in conjunction with or separately to
studies involving patients. Caregiver studies were eligible only for
informal or family caregivers (i.e., not paid caregivers or healthcare
professionals), although studies involving interventions target-
ing healthcare professionals were eligible where the aim of the
intervention was to ultimately improve information provision to
primary brain tumor patients or caregivers.
SEARCH METHODS FOR IDENTIFICATION OF STUDIES
Searches of PubMed, MEDLINE, EMBASE, CINAHL (via EBSCO-
host), and PsychINFO (via EBSCOhost) were conducted for the
years 1980–2014, to identify reports of relevant studies. Search
terms used medical subject headings (MeSH) and keywords relat-
ing to brain tumors, patient education, doctor–patient communi-
cation, and information provision (see Box 1 for an illustration).
We also reviewed the reference lists of included studies and relevant
reviews for further references to relevant trials.
DATA COLLECTION AND ANALYSIS
Articles identified from all sources were downloaded into a refer-
ence management software package and duplicates were removed.
One author pre-screened all results (titles and abstracts) for
possible inclusion based on the inclusion criteria. The full text
of selected articles was then obtained and assessed against the
inclusion criteria. Data were extracted by one author using a
template, collecting study design, population, intervention char-
acteristics, and outcomes. Where data were missing or unclear,
or to obtain additional data, we attempted to contact lead study
authors, to obtain the data needed for analyses. Where necessary,
titles, abstracts, and full text were translated into English to allow
assessment and data collection.
Both authors independently assessed risk of bias in individual
studies in seven domains (random allocation sequence genera-
tion, allocation concealment, blinding of participants and person-
nel, blinding of outcome assessment, incomplete outcome data,
selective outcome reporting, and other sources of bias), taken
Box 1 Search terms used for MEDLINE.
Search Query content
S1 Brain neoplasms (MeSH)
S2 Neuro-oncology OR neuro-oncology (title/abstract)
S3 Glioma OR glioblastoma OR astrocytoma OR
meningioma OR schwannoma OR oligodendroglioma
OR medulloblastoma OR ependymoma (title/abstract)
S4 Brain tumor OR brain tumor OR brain cancer OR brain
neoplasm (title/abstract)
S5 1 OR 2 OR 3 OR 4
S6 Patient Education as Topic (MeSH)
S7 Professional Patient Relations (MeSH)
S8 Information Dissemination (MeSH)
S9 Consumer Health Information (MeSH)
S10 Pamphlets (MeSH)
S11 Audiovisual aids (MeSH)
S12 Information provision (title/abstract)
S13 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12
S14 5 AND 13
S15 Animals NOT humans (MeSH)
S16 14 NOT 15
S17 Limit date 1980–June 30 2014
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from the Cochrane Handbook of Systematic Reviews (36). Non-
randomized and single arm studies were assessed and reported as
being at a high risk of bias on the random allocation sequence
generation and allocation concealment items of the “Risk of bias”
tool. Risk of bias ratings was compared and consensus reached.
We had planned to pool the data across studies statistically
using meta-analysis but the heterogeneity in intervention types,
outcomes, and study designs meant that the data were unsuitable
for this. We have thus conducted a narrative synthesis of results,
grouping the data based on the category that best explores the het-
erogeneity of studies, in this case nature of the intervention (group
level, practice or process change, or individual level). Within each
category, we narratively summarized the results.
RESULTS
SEARCH RESULTS
Eight hundred and thirty-nine original articles were identified,
48 of which were assessed at the full text level for eligibility. The
screening and selection process is outlined in a PRISMA flow chart,
see Figure 1.
INCLUDED STUDIES
A total of 16 articles reporting on 13 studies involving more than
210 patients, 87 caregivers and 104 healthcare professionals were
selected for inclusion (Tables 1 and 2). Studies for which quanti-
tative data were available are described in Table 1; Table 2 reports
on the studies for which no quantitative results were reported.
Two studies were randomized controlled trials (37, 38), one was
a non-randomized trial with control group (39), and the remain-
der was single arm trials (40–48). Studies were most commonly
conducted in the US [6 studies (38, 41–44, 46)] and Australia [3
studies (39, 47)], with single studies conducted in Canada (40),
Austria (45), the Netherlands (37), and the UK (48). Six studies
involved patients only (37–39, 41, 42, 48), two targeted caregivers
only (43, 47), two healthcare professionals only (44, 47), and two
both patients and caregivers (45, 46). A single study reported
FIGURE 1 | Inclusion/exclusion process following article search.
patient and healthcare professional participants (40), although
only the patient participants were eligible for and included in
this review. Four studies did not specify the sample size (43, 48),
or data collection was in progress at the time of reporting (37,
42). Median participant sample sizes were 32 (range 13–50) for
patients, 39 (range 7–41) for caregivers, and 52 (range 43–61)
for healthcare professionals. One study was published only as a
protocol (37), and four studies only in conference abstracts (41–
43, 46). An attempt was made to contact corresponding authors
of all included studies in order to verify methods and to obtain
missing data, and six authors responded to requests for additional
information.
Five interventions were delivered at the group level, four inter-
vened to facilitate practice or process changes, and four were
individual level interventions. At the group level, two workshops
provided training in using compensatory strategies to manage
challenging behaviors; one half-day duration workshop deliv-
ered by a multi-disciplinary group covering didactic sessions and
clinician-facilitated discussions was for family members (47) and
the other 6-h workshop, also led by a multi-disciplinary team and
involving didactic presentations and small-group exercises, was for
healthcare professionals (47). A further workshop of 8 h duration
provided training for family members to develop practical care
skills and provide information about brain tumors (43). Schratter-
Sehn (45) and colleagues described a mixed patient/family mem-
ber information and support group, which took place monthly
with flexible attendance. Rabow and colleagues (44) developed
and screened a 48 min documentary film for neurosurgeons,
neuro-oncologists, and other clinicians to teach them about family
caregiving for patients with brain tumors.
At the practice or process level, Lima and colleagues (42)
described an evaluation currently in progress of a new survivor-
ship care model involving nurse practitioner survivorship visits in
coordination with neuro-oncologists. This intervention includes
scheduled survivorship visits, a personalized education notebook,
calendar, pedometer, and “walking challenge,” electronic med-
ical record-created “After Visit Summary” and written summaries
sent to all treatment team members. Delaney and colleagues
(40) described the integration of a pharmacist into the neuro-
oncology team, with the pharmacist meeting with or telephoning
patients three times during their course of chemotherapy, and
returning patient-initiated calls during this time. Pharmacists pro-
vided standardized counseling regarding chemotherapy adminis-
tration, managing side effects, dosing of supportive medications
and drug interactions, and communication with pharmacists,
and answered other medication-related questions. Green and col-
leagues described the use of a videoconferencing system to allow
brain tumor patients to undergo follow-up neuro-oncology visits
at a medical center closer to home, rather than having to attend
a tertiary hospital further away. Following the taking of history
and physical examination, clinical and laboratory data and neuro-
images were shared by desktop by a neuro-oncologist located at the
tertiary center. Finally within this category, Grimes and colleagues
described the evaluation of changes to a number of processes
within a hospital neurosciences service. Changes included doc-
umentation for staff relating to the patient admission process;
training programs for staff relating to the communication of “bad
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Table 1 | Characteristics of included studies reporting quantitative results.
Study (country) N Setting and participants Intervention characteristics
and comparison
Outcomes of interest
and measures
Reported findings
according to authors
RANDOMIZED CONTROLLEDTRIALS
El-Jawahri
et al. (38, 51)
(US)
50 Consecutive patients with
malignant glioma, recruited
via hospital oncology
outpatient clinics
Video after verbal narrative, describing
three levels of medical care in advanced
cancer (life-prolonging care, basic medical
care, comfort care). Six minute video
shown on portable computer included
visual images of the goals of care
described verbally. Comparison: verbal
narrative only
Knowledge (goals of care options
assessed via questionnaire, yielding score
0–6). Patient satisfaction (perceived value
of video, three items on 4-point Likert
scale) assessed for intervention group
only, immediately after intervention
Significantly higher mean increase in
knowledge score for intervention (mean
1.9, 95% CI, 1.3–2.4) than control group
(mean 0.9, 95% CI, 0.4–1.3), p=0.004.
Most intervention participants were “very
comfortable” watching the video (82.6%),
found it “very helpful” (78.3%), and
would “definitely recommend it” (82.6%)
NON-RANDOMIZEDTRIALS WITH CONTROL GROUP
Langbecker
et al. (39, 49,
50) (Australia)
20 Primary brain tumor patients
diagnosed in previous
6 months and/or undergoing
treatment, recruited via four
hospitals
Brain tumor-specific question prompt list
(booklet with list of questions patients
may wish to ask) designed to facilitate
patient-HCP communication with
questions about: diagnosis; prognosis;
symptoms and changes; treatment;
support; after treatment finishes; the
healthcare professional team. Control
participants given standard brochure only
Quantity and quality of information
received (assessed using EORTC
QLQ-INFO25 questionnaire); satisfaction
(acceptability of the intervention or
standard brochure assessed using
17 questions, combined into summative
index), collected 4–6 weeks after
intervention
Higher median change in information
received for intervention (2.7, range −24.0
to 18.6, n=9) than control group (−2.0,
range −36.0 to 9.3, n=8), indicating
greater information received. Median
acceptability score higher for intervention
(31, range 27–34) than control group (28,
range 15–31), indicating greater
acceptability
SINGLE ARM STUDIES
Grimes
(48)(UK)
NS Patients with brain tumors
using a neurosciences service
at a hospital
(1) New package of patient admission
process documentation covering issues
to discuss with/communicate to patients
at appropriate points during their stay;
(2) procedures to reduce time waiting for
biopsy result and for nurse to coordinate
meeting to delivery results to patient;
(3) communication training programs for
staff; (4) information to familiarize patients
with the hospital and covering types of
diseases, treatments, and support
services
Patients’ views on clarity of explanation,
collected via survey using visual analog
scales following patients’ receipt of their
biopsy results. Collected prior to and
6 months after implementation of
intervention
At baseline, 48% rated clarity of
explanation; this was 73% after
intervention (no data supplied to interpret
result)
(Continued)
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Table 1 | Continued
Study (country) N Setting and participants Intervention characteristics
and comparison
Outcomes of interest
and measures
Reported findings
according to authors
Delaney et al.
(40) (Canada)
13 Consecutive newly diagnosed
HGG patients undertaking
chemoradiotherapy at a
neuro-oncology outpatient
clinic
Pharmacist integration into
multi-disciplinary team. Initially took
medication history and provided
counseling re: chemotherapy
administration; side effect management;
dosing of supportive medications; drug
interactions; communication with
pharmacists; other medication-related
questions. Called patient the next day and
5 days after treatment initiation to address
medication-related questions and review
treatment protocols; patient could also
initiate contact
Patient satisfaction (perceptions of the
pharmacist and benefit of their
involvement in their healthcare team),
collected at the end of the 3-month study
11/11 participants reported receiving
useful information from pharmacist; 8/10
felt pharmacist’s presence was helpful in
their initial consultation; 7/10 said
pharmacist’s call on day 5 of treatment
was useful; 8/10 said pharmacist
answered additional drug-related
questions to their satisfaction; 9/10
recommend pharmacist remains part of
team
Green et al.
(41) (US)
38 Patients with primary brain
tumors living regionally from a
Neuro-oncology Center
Use of a videoconferencing system for
neuro-oncology follow-up visits, involving
history-taking, physical examination,
desktop sharing of clinical and laboratory
data using an electronic medical record,
sharing of neuro-images
Patient satisfaction (16 question online
survey), timing unclear
Average level of satisfaction reported by
patients was 9.8 (1–10 scale, SD not
reported)
Rabow et al.
(44) (US)
61 Neurosurgeons,
neuro-oncologists, and other
clinicians from a neurological
surgery or integrated
medicine department or
attending national
conferences
48 min documentary film entitled “The
Caregivers” depicting stories of four
family caregivers of adults with brain
tumors and designed to improve
neurosurgery training around supporting
family caregivers. Screenings held for
staff and at conferences
Satisfaction (perceived quality of the film,
perceived importance; belief they learned
something from the film, believe that the
film was an effective way to teach about
family caregivers, belief that the film
should be seen by all clinicians caring for
patients with brain tumors, collected on
10-point Likert scale) immediately after
screening
Mean scores: 9.27 for quality; 9.03 for
importance; 9.67 for learning something
new; 8.98 for the film being an effective
way to teach; 9.23 for the film should be
seen by all clinicians (SDs not reported)
(Continued)
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Table 1 | Continued
Study (country) N Setting and participants Intervention characteristics
and comparison
Outcomes of interest
and measures
Reported findings
according to authors
Schratter-Sehn
et al. (45)
(Austria)
104 Patients with high-grade
glioma (glioblastoma, mixed
glioma and astrocytoma) and
their relatives recruited
through neuro-oncology ward
at hospital
Interdisciplinary group intervention led by
a psychologist and physician, offered
monthly, for participants to receive or
exchange information. Flexible group
therapy with 6–10 participants covering up
to 2 therapy units (1.5 h). Aims: to be
responsive to each participant’s needs
and develop coping strategies, based on
principle of “care, encourage, inform, and
guide”
Satisfaction (how much participants liked
the intervention) assessed via
questionnaire, timing unclear
92% of participants said the intervention
provided a context in which they could
openly talk about their anxieties, concerns
and needs. 93% indicated their questions
were answered through the intervention.
Requirements and expectations were met
for 82% of patients and 78% of relatives
Whiting et al.
study 1 (47,
52) (Australia)
7 Family caregivers of adult
primary brain tumor patients
who had participated in
previous descriptive study
Half-day didactic workshop delivered by
multi-disciplinary team to train family
members in compensatory strategy use
to manage challenging behaviors (reasons
for, types of and strategies for managing
behavioral and cognitive changes).
Caregivers and patients attended
sessions together with clinician-facilitated
discussion
Knowledge and use of compensatory
strategies, measured via Strategy Use
Measure (SUM-Family), a 9-item
Likert-type scale; satisfaction (usefulness
of each workshop section) assessed via
questionnaire immediately after workshop
Median SUM-Family global scores
significantly increased from before (3.29,
IQR=0.80) to after (3.86, IQR=0.81) the
intervention, p<0.05. Average rating of
the workshop was 4.73 (4=good;
5= very good)
Whiting et al.
study 2 (47,
52) (Australia)
43 HCPs recruited via
professional networks
6 h workshop delivered by
multi-disciplinary team including didactic
presentations and small-group exercises
covering the journey of a brain tumor
patient, description of challenging
behaviors and prevalence following brain
tumor; principles of behavior
management; case study and group
activity
Knowledge of compensatory strategies
measured via Strategy Use Measure
(SUM), a 16-item Likert-type scale
developed for study); satisfaction
(evaluation of all sections of workshop)
assessed immediately after workshop
Average SUM rating scores significantly
increased from before (3.17) to after (4.1)
the intervention (SDs not provided, paired
t -test p<0.001). Satisfaction mean
scores were≥4 (4=good; 5= very good)
HCP, healthcare professional; CNS, central nervous system; NS, not specified; EORTC QLQ-INFO25, European Organisation for Research and Treatment of Cancer Information module; SD, standard deviation;
IQR, interquartile range.
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Table 2 | Characteristics of included studies not reporting quantitative results.
Study (country) N Setting and participants Intervention characteristics
and comparison
Outcomes of interest
and measures
Reported findings
according to authors
RANDOMIZED CONTROLLEDTRIALS
Boele et al. (37)
(The Netherlands)
NS Adult grade II, III or IV
glioma patients with
mild-moderate
depressive symptoms
and their informal
caregivers, recruited
through advertising and
treating HCPs
Internet-based self-help course based on
principles of problem solving, with information
about specific diseases and treatment, and
psychological impact on everyday life. Five
modules (text and exercises), 2 h/week over
5 weeks. Feedback from personal coach. Wait
list control and non-CNS malignancy control
group
Satisfaction (usability, readability,
usefulness of the course and
coach’s feedback assessed by
questionnaire) immediately and
6 months after intervention
Data collection in progress
SINGLE ARM STUDIES
Lima et al. (42)
(US)
NS Newly diagnosed
primary brain tumor
patients at a
Comprehensive Cancer
Center
Survivorship care delivery model involving nurse
practitioner survivorship visits in coordination
with primary neuro-oncologist. Aims: to identify
and manage symptoms and distress; patient
education; facilitation of communication among
care providers; navigation of resources. Visits
scheduled within 3 weeks of diagnosis and at
specific points in the disease trajectory.
Included personalized education notebook,
calendar, pedometer, and “walking challenge,”
after visit summary and written summaries sent
to all treatment team members
Satisfaction regarding initial
survivorship visit and patient
education notebook (collected by
survey), timing unclear
Data collection in progress
Patterson and
Lovely (43) (US)
NS Family caregivers of
brain tumor patients,
implemented at
medical centers
8-h workshop curriculum providing information
on topics such as medical overview of brain
tumors, symptom management at home,
understanding cognitive changes, how to safely
move a patient. Offered by oncology nurses and
aims to develop practical care skills
Caregiver knowledge (measured by
questionnaire), satisfaction (overall
benefit of the workshop as
perceived by participants), timing
unclear
No results reported
Spezeski et al.
(46) (US)
75 Callers to a
neuro-oncology
telephone service (35%
patients, 52%
family/friend of patient)
Neuro-oncology information telephone line
providing information on topics such as brain
tumor types and treatments, caregiving issues,
symptom management, and referrals to
support-related resources
Satisfaction (measurement tool
unclear)
“Callers expressed satisfaction with their
experience and found the information to be
quite helpful” (p. 549). “Virtually all callers
said they would recommend the hotline to
others needing information about brain
tumors” (p. 549)
HCP, healthcare professional; NS, not specified.
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Table 3 | Risk of bias for included studies.
Study Random
sequence
generation
Allocation
concealment
Blinding of
outcome
assessment
Incomplete
outcome data
Selective
reporting
Boele et al. (37) Low Low High Uncleara Uncleara
El-Jawahri et al. (38, 51) Low Low High Low Unclear
Langbecker et al. (39, 49, 50) High High High Low Low
Grimes (48) High High High Unclear Unclear
Delaney et al. (40) High High High Low Unclear
Green et al. (41) High High High Unclear Unclear
Lima et al. (42) High High High Uncleara Uncleara
Patterson and Lovely (43) High High High Unclear Unclear
Rabow et al. (44) High High High Low Low
Schratter-Sehn et al. (45) High High High Unclear Unclear
Spezeski et al. (46) High High High Unclear Unclear
Whiting et al. study 1 (47, 52) High High High Unclear Unclear
Whiting et al. study 2 (47, 52) High High High Low Unclear
aUnclear risk as data collection in progress.
news” to patients; documentary information for patients and fam-
ilies covering types of disease, treatment, and support services; new
systems for the management of scans and biopsy results; and a
half hour preparation session for patients held at the beginning of
each neuro-oncology clinic, during which patients were allocated
to a single clinician based on their needs (rather than seeing each
clinician as done previously).
At the individual level, a wide variety of interventions were
evaluated. El-Jawahri and colleagues (38) tested a 6-min video
designed to facilitate end-of-life discussions in a randomized con-
trolled trial. The video depicted life-prolonging care [for exam-
ple, including cardiopulmonary resuscitation (CPR), intubation
and mechanical ventilation], basic care (including hospitalization,
intravenous fluids, and antibiotics but excluding CPR, etc.) and
comfort care (usually including medications to improve symptoms
but not hospitalization). Boele and colleagues (37) described a
self-administered internet-based intervention based on problem-
solving therapy for glioma patients with mild to moderate depres-
sive symptoms. The intervention consisted of five modules with
text and exercises, with feedback provided by a personal coach.
Spezeski and colleagues (46) described the evaluation of a neuro-
oncology information hotline, which patients and caregivers could
call as desired and which covered topics ranging from brain tumor
types and treatments, caregiving issues, symptom management,
and referrals to support-related resources. Langbecker and col-
leagues (39) tested a brain tumor-specific question prompt list,
which is a structured list of questions for patients to ask of health-
care professionals if they wish and which may foster the provision
of tailored, personally relevant information.
The most commonly reported outcome was satisfaction with
the intervention, assessed in some form (e.g., found the inter-
vention helpful or acceptable) by 12 of the 13 studies (37–47,
49–52). Four studies assessed knowledge by questionnaire (38,
43, 47) in terms of knowledge of different levels of medical
care in the advanced stage of cancer (38), knowledge and use
of compensatory strategies to manage behavioral and cognitive
changes (47), or caregiver knowledge not further defined (43).
Two studies assessed information provision (39, 48). No studies
assessed recall or understanding, and only two studies assessed
more distal outcomes such as quality of life (37, 39). Outcomes
were most commonly assessed immediately after the intervention
(37, 38, 44, 47), although the timing of assessment was not clear
in six studies (41–43, 45, 46, 48).
RISK OF BIAS IN INCLUDED STUDIES
Both randomized controlled trials (37, 38) were rated as low
risk for random sequence generation and allocation concealment
(Table 3). As all other studies were non-randomized or single
arm studies, risk was rated as high for these biases. Blinding of
outcome assessment was rated only for the three studies with con-
trol groups, and was rated as high for all three (37, 38, 49) as
well as all single arm studies due to the nature of the interven-
tions. Five studies (38–40, 44, 47) were rated as low risk with
regard to incomplete outcome data, with all other studies rated as
unclear risk due to absence of a published protocol. Only two
studies (39, 44) were rated as low risk for selective reporting,
with corresponding authors confirming that all outcomes were
reported.
EFFECTS OF INTERVENTIONS
The effects of interventions are reported only for the studies
described in Table 1, for which quantitative results are available.
Where appropriate, we have highlighted where studies assessed
outcomes but did not report the results of these outcomes.
Outcome: information provision
One non-randomized study and one single arm study assessed
information provision (39, 48). Grimes (48) compared the views
of inpatients on the clarity of information provided to them
before and after intervention implementation. Patient-reported
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clarity of explanation increased from 48 to 73% after the inter-
vention (no information was provided to explain how to inter-
pret these percentages). Langbecker and colleagues (39) assessed
the quality and quantity of information received by participants
using the European Organisation for Research and Treatment
of Cancer (EORTC) information module (QLQ-INFO25). In a
non-randomized trial, the median change in information received
between baseline and follow-up was higher for intervention group
participants (a brain tumor-specific question prompt list) com-
pared to brochure only controls. However, statistical testing of
the significance of these group differences was not reported, and
the sample size was small, with follow-up data collected for 17
of 20 participants only due to attrition. Overall, both studies
showed that greater information was provided to participants
who received the interventions compared to those who did not,
although the high risk of bias for both studies for randomiza-
tion, allocation concealment, and blinding of outcome assessment
limits the confidence that can be had in these findings.
Outcome: knowledge
One randomized controlled trial (38) tested a video and three
single arm pre-/post-test studies (43, 47) tested the effect of
workshop-delivered interventions on participants’ knowledge;
however, no results were reported for one study, which evalu-
ated the effect of a workshop for family members (43). Among
the three studies for which results were available, the randomized
controlled trial showed a statistically significantly greater mean
increase in patients’ knowledge of the different levels of medical
care in the advanced stages of cancer for patients who received
the video intervention compared to those who received the con-
trol condition (38). Compared to pre-workshop levels, Whiting
and colleagues’ (47) interventions led to statistically significantly
increases in participant knowledge (for family members and for
healthcare professionals) following the workshops.
Although these results are promising, study-specific instru-
ments were used to assess knowledge for all three of these studies
(38, 43, 47). Whiting et al. (47) reported that the instrument
(the Strategy Use Measure) used to assess knowledge for health-
care professionals (and a modified version of this was also used
to assess knowledge for family members) showed strong inter-
nal consistency and did not demonstrate ceiling or floor effects
(47). While this psychometric information demonstrates reliabil-
ity, the validity of the instrument and its sensitivity to change is
unclear.
The contextual significance of these results is also unclear. Sta-
tistical significance may be shown with a large enough sample
even if the clinical or contextual significance of the findings is
unremarkable. However, the sample sizes of three studies were
small, including 50 patients (38), 7 family members (47), and 43
healthcare professionals (47). The presence of statistically signif-
icant results with such small samples provide support for the
significance of the results, but further research to validate the
instruments and establish the significance of different levels of
change is needed.
Risk of bias was not significantly different across the three stud-
ies for which data were available, so sub-analysis of the impact of
risk of bias was not possible.
Outcome: satisfaction
Twelve studies (37–47) considered satisfaction with the interven-
tion as an outcome, and nine studies reported (38–41, 44–47)
data relating to this outcome, primarily described as the interven-
tion’s acceptability, perceived usefulness, value, or quality. Among
the nine studies for which results were available, only one study
reported comparative data for intervention and control groups;
Langbecker et al. (39) reported that a greater proportion of par-
ticipants who received a question prompt list compared to those
who received a control brochure highly agreed that the brochure
was helpful, assisted them to ask questions, and other satisfaction
items. All other studies reported satisfaction in intervention group
participants only. They found high rates of satisfaction, evidenced
by mean satisfaction scores of at least 8 out of 10 (or equivalent),
or at least 80% of participants selecting the highest rating on a
Likert-type scale. This was true regardless of the nature of the
intervention, whether it was delivered in a group or individual set-
ting, or constituted a practice or process change, and regardless of
the risk of bias of the studies involved.
DISCUSSION
Our findings suggest that if an intervention is provided to patients
with brain tumors, their caregivers, or the healthcare professionals
who treat these patients, satisfaction ratings improve. These find-
ings are based largely on non-randomized pre–post single arm
intervention studies, mostly with relatively small sample sizes.
Although similar to reports from previous reviews in the wider
cancer population, the analyses focusing on those affected by brain
tumors reported here provide additional insight. First, the review
provides evidence for the feasibility of conducting studies with this
patient and caregiver population. This is important as some may
doubt that the highly distressed and often cognitively impaired
population may be willing to be included in such investigations.
Based on this review’s findings, those who agree to participate
can be reassured that they will benefit at least subjectively. The
reviewed studies also provide suggestions for optimizing data col-
lection in the brain tumor patient population to reduce study
burden, such as collecting data immediately after the intervention
(38) or collecting data by interview rather than self-administered
forms (39). Both of these strategies are recommended for palliative
care research and may have value in this population (53).
However, the review also highlights a lack of stringent outcome
measurements, which can be compared across studies or can be
objectivized. This could include standardized tests of knowledge
or improvements in treatment compliance, which often are tar-
get aims, but were seldomly formally assessed. Notable exceptions
are the study by El-Jawahri et al. (38), who used a standardized
knowledge score as outcome measure, and Langbecker et al. (39),
who used an EORTC module to assess improvements in informa-
tion. The most appropriate outcomes to measure in future studies
must also be considered. Satisfaction with the intervention was the
most commonly assessed outcome, but this concept lacks theoret-
ical underpinning and may not be a good indicator of intervention
quality (54). The use of global satisfaction ratings is particularly
susceptible to the “halo effect” whereby raters overestimate perfor-
mance with global impressions influencing responses to specific
items. In interventions involving health professionals,patients may
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also report on the clinicians’ interpersonal skills rather than the
clinicians’ technical competence or the intervention’s usefulness
(55, 56). It is hoped that the emergence of standardized tools
such as the EORTC QLQ-INFO25 will encourage the assessment
of information provision and related constructs, thus provid-
ing greater understanding of whether interventions achieve real
change and allowing comparison across studies of intervention
effects. If satisfaction ratings are to be used, it is recommended
that surveys emphasize that the ratings will be used to improve
the intervention (rather than merely to evaluate it) and include
more items assessing specific aspects of the intervention, rather
than using a global rating. Both of these suggestions have been
shown to reduce the impact of the halo effect (56).
The number of studies conducted with this population seemed
to increase over time, with several conducted during the most
recent decade. This is promising and may reflect a renewed inter-
est in improving the treatment outcomes for patients with brain
tumors, and also the encouragement provided through success-
fully conducted previous studies. Most studies, however, employed
research designs that resulted in either high risk of bias or inabil-
ity to assess risk of bias, lacking a published study protocol and a
control group in most instances. Although the nature of the inter-
ventions mean that it would not be possible to blind participants to
study outcomes, blinding of assessors would be feasible. Greater
specification of analysis methods (for example, if intention-to-
treat analysis was carried out) is also needed. Finally, none of the
included studies investigated whether intervention efficacy was
affected by patients’ cognitive status, despite cognitive impairment
being a common issue in this population (29, 31, 32). This should
be considered in future studies.
STRENGTHS AND LIMITATIONS OF THIS REVIEW
To the best of our knowledge, this is the first systematic review
of interventions to improve information provision for adult pri-
mary brain tumor patients and their caregivers. Strengths of this
systematic review include the extensive search of the literature in
multiple databases, the inclusion of publications written in lan-
guages other than English, and the assessment of risk of bias of
included studies. However, due to the limited number of stud-
ies, heterogeneity in interventions and methods, and inadequate
reporting of data for some studies, we were unable to statistically
pool the study results to determine the relative benefit of different
interventions. Further work is necessary to determine the most
effective intervention components and most appropriate timing
for intervention delivery, as well as the effect of interventions on
more distal outcomes such as quality of life, treatment adherence,
or survival.
CONCLUSION
This systematic review showed that interventions with an educa-
tional component improve information provision and knowledge
for adults with brain tumors, their families, and caregivers. Fur-
thermore, satisfaction with these interventions was high. Although
these results are promising, future efficacy and effectiveness trials
with rigorous study designs are needed, particularly to determine
the most useful intervention components and to understand if
certain subgroups of the population are differentially affected.
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